Assessment of symptoms in myalgic encephalomyelitis/chronic fatigue syndrome: a comparative study of existing scales.
Lu, Jing, Sun, Weibo, Li, Shulin et al. · Frontiers in neurology · 2025 · DOI
Quick Summary
This review examined the different questionnaires and tests doctors use to measure ME/CFS symptoms. The researchers looked at how well these tools work for diagnosing the illness and tracking how patients change over time. They found that while current tests are reasonably reliable, we need better tools that measure all the different ways ME/CFS affects people—like fatigue, brain fog, pain, and sleep problems—in a more consistent and objective way.
Why It Matters
Since ME/CFS lacks reliable biological markers, accurate symptom measurement is critical for diagnosis and comparing results across research studies. This review helps identify which assessment tools work best and where improvements are needed, potentially accelerating better diagnosis and treatment development for patients. Understanding measurement strengths and weaknesses can guide clinicians toward more reliable tools for patient care.
Observed Findings
Existing ME/CFS symptom assessment scales demonstrate acceptable reliability across studies
Existing scales vary significantly in their sensitivity (ability to detect disease when present) and disease specificity (ability to exclude other conditions)
Current assessment tools show limitations in comprehensively measuring the multidimensional nature of ME/CFS symptoms
No single standardized scale currently captures all major symptom domains (fatigue, PEM, cognitive dysfunction, sleep, pain, orthostatic intolerance, and functional impairment) with equal effectiveness
Gaps exist between what is measured and what is needed for both clinical diagnosis and research comparability
Inferred Conclusions
Harmonized, multidimensional assessment instruments are needed to improve diagnostic precision in ME/CFS
Digital or objective validation methods could enhance the reliability and clinical utility of symptom measurement tools
Improved standardized measures are essential for better longitudinal monitoring of patients and comparability across research studies
Clinical translation of ME/CFS research requires assessment tools that more accurately capture the disease's complex symptom profile
Remaining Questions
What This Study Does Not Prove
This review does not establish whether any particular symptom scale can definitively diagnose ME/CFS or predict disease progression. It does not present new clinical data or test any new assessment tool; rather, it evaluates existing instruments. The review does not prove causation for any ME/CFS symptoms—it only examines how well current tools measure the symptoms that are already known to occur in the disease.